Presentation is loading. Please wait.

Presentation is loading. Please wait.

Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases  Felix G. Fernandez, MD, Benjamin D. Kozower,

Published byDalibor Ćirković Modified over 6 years ago

Similar presentations

Presentation on theme: "Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases  Felix G. Fernandez, MD, Benjamin D. Kozower,"— Presentation transcript:

1 Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases  Felix G. Fernandez, MD, Benjamin D. Kozower, MD, MPH, Traves D. Crabtree, MD, Seth D. Force, MD, Christine Lau, MD, Allan Pickens, MD, Alexander S. Krupnick, MD, Nirmal Veeramachaneni, MD, G. Alexander Patterson, MD, David R. Jones, MD, Bryan F. Meyers, MD, MPH  The Journal of Thoracic and Cardiovascular Surgery  Volume 149, Issue 1, Pages e1 (January 2015) DOI: /j.jtcvs Copyright © Terms and Conditions

2 Figure 1 Flow diagram demonstrating enrollment, allocation, and analysis of patients in this prospective observational cohort study. SUV, Standardized uptake value; VATS, video-assisted thoracoscopic surgery. The Journal of Thoracic and Cardiovascular Surgery  , e1DOI: ( /j.jtcvs ) Copyright © Terms and Conditions

Download ppt "Utility of mediastinoscopy in clinical stage I lung cancers at risk for occult mediastinal nodal metastases  Felix G. Fernandez, MD, Benjamin D. Kozower,"

Similar presentations

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Stephen R. Broderick, MD, MPHS 

Stephen R. Broderick, MD, MPHS 
The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.

The eighth edition TNM stage classification for lung cancer: What does it mean on main street?  Frank C. Detterbeck, MD  The Journal of Thoracic and Cardiovascular.
Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,

Evaluation of the Reliability of Clinical Staging of T2 N0 Esophageal Cancer: A Review of The Society of Thoracic Surgeons Database  Traves D. Crabtree,
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible  Alessandro Brunelli,
Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer?  Traves D. Crabtree, MD, Varun Puri,
Lung cancer screening: No more excuses

Lung cancer screening: No more excuses
Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M
Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer  Hong.
Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data.

Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data.
National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer  Aalok P. Patel, BS, Traves D. Crabtree,

National Patterns of Care and Outcomes After Combined Modality Therapy for Stage IIIA Non–Small-Cell Lung Cancer  Aalok P. Patel, BS, Traves D. Crabtree,
Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D
Benefits of resection for metachronous lung cancer

Benefits of resection for metachronous lung cancer
Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.

Patterns of survival and recurrence after surgical treatment of early stage non–small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial  Stacey.
Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer  Usman Ahmad, MD, Traves D. Crabtree,

Adjuvant Chemotherapy Is Associated With Improved Survival in Locally Invasive Node Negative Non-Small Cell Lung Cancer  Usman Ahmad, MD, Traves D. Crabtree,
Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer  Pamela Samson, MD, MPHS, Traves.

Defining the Ideal Time Interval Between Planned Induction Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer  Pamela Samson, MD, MPHS, Traves.
A bilobed thoracic outlet mass: Options for resection

A bilobed thoracic outlet mass: Options for resection
Abbas Emaminia, MD, Sara A

Abbas Emaminia, MD, Sara A
Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival  Pamela Samson, MD, MPHS, Traves.

Quality Measures in Clinical Stage I Non-Small Cell Lung Cancer: Improved Performance Is Associated With Improved Survival  Pamela Samson, MD, MPHS, Traves.

Similar presentations

Ads by Google